These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33423668)

  • 21. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary application of transjugular intrahepatic portosystemic shunt in individualized treatment of patients with cirrhotic portal hypertension complicated with refractory ascites and variceal hemorrhage].
    Jiang MM; Xu H; Zhang QQ; Wei N; Xu W; Cui YF; Liu HT; Zu MH; Wang WL; Gao ZK
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(47):3737-3740. PubMed ID: 31874500
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS.
    Queck A; Schwierz L; Gu W; Ferstl PG; Jansen C; Uschner FE; Praktiknjo M; Chang J; Brol MJ; Schepis F; Merli M; Strassburg CP; Lehmann J; Meyer C; Trebicka J
    Hepatology; 2023 Feb; 77(2):466-475. PubMed ID: 35869810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
    Ghannam JS; Cline MR; Hage AN; Chick JFB; Srinivasa RN; Dasika NL; Srinivasa RN; Gemmete JJ
    Pediatr Radiol; 2019 Jan; 49(1):128-135. PubMed ID: 30291382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.
    Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R
    Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India.
    Amarapurkar DN; Punamiya S; Patel ND
    Ann Hepatol; 2006; 5(2):103-8. PubMed ID: 16807516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
    Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
    JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study.
    Wang C; Wang Y; Zhao J; Yang C; Zhu X; Niu H; Sun J; Xiong B
    Heliyon; 2024 Jan; 10(1):e23455. PubMed ID: 38163189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft.
    Wan YM; Li YH; Xu Y; Wu HM; Li YC; Wu XN; Yang JH
    Acad Radiol; 2018 Jul; 25(7):925-934. PubMed ID: 29373208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children.
    Lv Y; He C; Guo W; Yin Z; Wang J; Zhang B; Meng X; Cai J; Luo B; Wu F; Niu J; Fan D; Han G
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):233-41. PubMed ID: 26381818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
    Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.